Company Quick10K Filing
Weyland Tech
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-15
S-1 2018-12-17 Public Filing
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-11
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-12
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-03-27
10-Q 2013-09-30 Filed 2013-11-08
10-Q 2013-06-30 Filed 2013-08-09
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-10-22
10-Q 2012-08-08 Filed 2012-08-08
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-03-27
8-K 2020-11-05
8-K 2020-11-04
8-K 2020-10-30
8-K 2020-10-13
8-K 2020-09-30
8-K 2020-09-25
8-K 2020-09-01
8-K 2020-08-28
8-K 2020-08-11
8-K 2020-07-31
8-K 2020-04-16
8-K 2020-03-25
8-K 2020-02-25
8-K 2020-01-08
8-K 2019-12-16
8-K 2019-11-25
8-K 2019-11-15
8-K 2019-08-19
8-K 2019-07-22
8-K 2018-10-05
8-K 2018-09-24
8-K 2018-09-20
8-K 2018-08-16
8-K 2018-02-12

Weyland Tech Financials

WEYL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-08-082012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash664059143518306543516504297254304304472002,3801,7639491,0041,3501,2407601,0561,0099407311,3865,3035,821
Accounts Receivable7401,7347370000
Inventory
PP&E8865432210
Assets241347641487724685455175052972543043041686916313,8284,2715,4013,3965,4965,3185,9455,2976,2535,6905,4896,30710,60211,699
Accounts Payable13417341442942940406965270175474218181818888773
Long-Term Debt
Liabilities6003665184844994995124095474824364224054053829148571,9081,4611,8238441,4862,0202,7492,0473,0663093796395,2802,218
Stockholders' Equity-576-353-420-351273-45136-3023-139-169-101-101-214-223-2271,9202,8093,5782,5524,0103,2983,1953,2513,1865,3805,1095,6685,3239,482
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-08-082012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8,4368,4927,1428,996
Cost of Revenue3383125881,0181,7621,280629803402244543677969-336475956342,9931,7112,4341,0404,0553,2922,8805121,0336,9845,8747,400
Gross Profit-74272224490-337-209255596-35-99246674-14387551,6271,1401,0681,3351,7973135352,3953,6687,4031,5071,2681,597
R&D1,2094,5118681,2431,126
SG&A21956526423319224315822650425839227847517529514141743252622332512285539062,8784,8226411,6701,558
Tax0
Net Income-224-642-867-246307-639-36527200-290-492-32200-19195-9-91,3709207681,458-23-102-718-507-1,998-27-1,671-1,081
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-08-082012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-34935-235-670-5528-147-48-458-435001680-4021,393-700-1,084127-18254-480-89-489692,591-4,722
Cash Investing000-157001630000000-100-60-110-72900000
Cash Financing349020050120322500000001,547-1,1503806573644425861,326